Edelweiss' report onCyient
Cyient’s Q4FY17 revenue, at USD141.0mn (up 3.8% QoQ), was ahead of Street’s 3.2% growth estimate. EBITDA margin, at 13.3% (down 10bps QoQ), was lower than Street’s 13.8% estimate. Management has guided for 12.5% revenue growth and 50bps margin expansion for FY18 leading to double-digit earnings growth.
Outlook
We remain positive on the stock given its significantly better growth profile versus peers due to exposure to the Engineering Research & Development (ER&D) & IoT segments. Maintain ‘BUY’ with a revised target price of INR 605 (INR 620 earlier) as we change USD rates to INR 67 from INR 69.
For all recommendations, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.